Shuttle Pharmaceuticals Insider Trades
NASDAQ: SHPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 6 · $181.76K
- Sales
- 5 · $504.83K
- Shares bought / sold
- 53.40K / 121.28K
- Net activity
- Net selling $323,067
Shuttle Pharmaceuticals insider activity
Over the last 12 months, Shuttle Pharmaceuticals insiders reported 11 transactions on SEC Form 4: 6 open-market purchases and 5 sales. Insiders bought $181,764 and sold $504,832 worth of stock, for net insider selling of $323,067. The largest seller was HRT FINANCIAL LP, with $504,832 in reported sales.
The most recent filing shows HRT FINANCIAL LP (10% Owner) selling 82,116 shares at $4.48 on Jul 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SHPH's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SHPH insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 14, 2026 | HRT FINANCIAL LP10% Owner | Sale | 82,116 | $367.88K | Form 4 |
| Jul 13, 2026 | HRT FINANCIAL LP10% Owner | Sale | 1,033 | $4.82K | Form 4 |
| Jul 10, 2026 | HRT FINANCIAL LP10% Owner | Buy | 731 | $2.27K | Form 4 |
| Jul 9, 2026 | HRT FINANCIAL LP10% Owner | Buy | 8,266 | $27.94K | Form 4 |
| Jul 8, 2026 | HRT FINANCIAL LP10% Owner | Sale | 18,531 | $65.23K | Form 4 |
| Jul 7, 2026 | HRT FINANCIAL LP10% Owner | Sale | 10,580 | $35.23K | Form 4 |
| Jul 6, 2026 | HRT FINANCIAL LP10% Owner | Sale | 9,022 | $31.67K | Form 4 |
| Jul 2, 2026 | HRT FINANCIAL LP10% Owner | Buy | 7,851 | $27.79K | Form 4 |
| Jul 1, 2026 | HRT FINANCIAL LP10% Owner | Buy | 3,959 | $13.06K | Form 4 |
| Jun 30, 2026 | HRT FINANCIAL LP10% Owner | Buy | 6,755 | $21.82K | Form 4 |
| Jun 29, 2026 | HRT FINANCIAL LP10% Owner | Buy | 25,836 | $88.88K | Form 4 |
| May 1, 2024 | Jung MiraChief Scientific Officer | Award | 598 | $6.75K | Form 4 |
| Mar 8, 2024 | Vander Hoek MichaelChief Financial Officer | Award | 100,000 | — | Form 4 |
| Dec 13, 2023 | Jacobs BetteDirector | Sale | 4,157 | $1.93K | Form 4 |
| Dec 13, 2023 | Brown MiltonDirector | Sale | 2,921 | $1.35K | Form 4 |
| Aug 14, 2023 | Dritschilo AnatolyCEO and Chairman | Gift | 2,100,000 | — | Form 4 |
| Aug 14, 2023 | Dritschilo AnatolyCEO and Chairman | Gift | 2,100,000 | — | Form 4 |
| Dec 29, 2022 | Vander Hoek MichaelChief Financial Officer | Sale | 2,243 | $3.60K | Form 4 |
| Dec 29, 2022 | Dritschilo PeterPresident and COO | Sale | 3,820 | $6.13K | Form 4 |
| Dec 29, 2022 | Jacobs BetteDirector | Sale | 4,366 | $7.01K | Form 4 |
| Dec 29, 2022 | Jung MiraChief Scientific Officer | Sale | 328 | $526.44 | Form 4 |
| Dec 29, 2022 | Rich TyvinChief Medical Officer | Sale | 1,414 | $2.27K | Form 4 |
| Dec 29, 2022 | Dritschilo AnatolyCEO and Chairman | Sale | 8,372 | $13.44K | Form 4 |
| Dec 29, 2022 | Adkins WilliamFormer Director | Sale | 995 | $1.60K | Form 4 |
| Dec 29, 2022 | Brown MiltonDirector | Sale | 995 | $1.60K | Form 4 |
| Dec 29, 2022 | Richards Steven MDirector | Sale | 995 | $1.60K | Form 4 |
| Dec 29, 2022 | Senanayake ChrisDirector | Sale | 1,626 | $2.61K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4